GSK372475 Bioequivalence Study

NCT00488098 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects
Depressive Disorder

Interventions

DRUG: GSK372475

Sponsor

GlaxoSmithKline